טאזופיפ 4.5 גרם
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
PIPERACILLIN AS SODIUM 4000 MG; TAZOBACTAM AS SODIUM 500 MG
Disponibbli minn:
PERRIGO ISRAEL AGENCIES LTD
Kodiċi ATC:
J01CA12
Għamla farmaċewtika:
POWDER FOR SOLUTION FOR INJECTION
Rotta amministrattiva:
I.V
Manifatturat minn:
HOSPIRA HEALTHCARE INDIA PVT. LTD
Grupp terapewtiku:
PIPERACILLIN
Indikazzjonijiet terapewtiċi:
Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazo-pip in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.
Data ta 'l-awtorizzazzjoni:
2010-08-01
